Evidence map›Paper›PMID 42014777›Full record

ReviewCommunications medicine2026

Perspectives from a multi-stakeholder workshop for implementing a risk-stratified breast cancer screening program in Canada.

Nareh Safieh-Garabedian, Antonis C Antoniou, Jennifer Brooks, June Carroll, Mathias Cavaillé, Jocelyne Chiquette, M J DeCoteau, Gregory Doyle, Andrea Eisen, Laurence Eloy and 21 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Communications medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Nareh Safieh-GarabedianCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. ns951@cam.ac.uk.ORCID http://orcid.org/0000-0002-8167-2639
Antonis C AntoniouCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Jennifer BrooksDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.ORCID http://orcid.org/0000-0001-7574-4256
June CarrollRay D. Wolfe Department of Family Medicine, Mount Sinai Hospital, Sinai Health, Toronto, ON, Canada.
Mathias CavailléDepartment of Pediatrics, Faculty of Medicine, Université Laval, Quebec City, QC, Canada.
Jocelyne ChiquetteOncogenetic Services, CHU de Québec-Université Laval, Quebec City, QC, Canada.
M J DeCoteauRethink Breast Cancer, Toronto, ON, Canada.
Gregory DoyleCancer Care, Newfoundland and Labrador Health Services, St. John's, NL, Canada.
Andrea EisenOntario Health, Toronto, ON, Canada.
Laurence EloyProgramme québécois de cancérologie, Ministère de la Santé et des Services sociaux, Quebec City, QC, Canada.
Samantha FeinbergDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Vivianne FreitasJoint Department of Medical Imaging, University of Toronto; University Health Network; Sinai Health System; Women's College Hospital, Toronto, ON, Canada.
Kim HenderDiagnostic Imaging (Radiology), Queen Elizabeth Hospital (QEH), Health PEI, Charlottetown, PEI, Canada.
Supriya KulkarniJoint Department of Medical Imaging, University of Toronto; University Health Network; Sinai Health System; Women's College Hospital, Toronto, ON, Canada.
Cynthia Mbuya-BiengeCHU de Québec-Université Laval Research Center, Quebec City, QC, Canada.
Christine MolnarDepartment of Radiology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Hermann NabiCHU de Québec-Université Laval Research Center, Quebec City, QC, Canada.
Caroline SamsonDepartment of Radiology, Radio-Oncology and Nuclear Medicine, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.
Jean M SeelyDepartment of Radiology, University of Ottawa, Ottawa, ON, Canada.ORCID http://orcid.org/0000-0003-0367-2219
Amanda J SheppardDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Penny SoucyGenomics Center, CHU de Québec-Université Laval Research Center, Quebec City, QC, Canada.
Romeo TagyenDepartment of Health, Government of Nunavut, Iqaluit, NU, Canada.
Isabelle TropDepartment of Radiology, Radio-Oncology and Nuclear Medicine, Faculty of Medicine, University of Montreal, Montreal, QC, Canada.
Annie TurgeonCHU de Québec-Université Laval Research Center, Quebec City, QC, Canada.
Marc VenturiCanadian Association of Radiologists, Ottawa, ON, Canada.
Nancy WaddenFaculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada.
Meghan WalkerDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Michael WolfsonUniversity of Ottawa Faculty of Medicine, Ontario, ON, Canada.
Anna ChiarelliDalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Jacques Simard *CHU de Québec-Université Laval Research Center, Quebec City, QC, Canada. jacques.simard@crchudequebec.ulaval.ca.ORCID http://orcid.org/0000-0001-6906-3390
Nora Pashayan *Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. np275@medschl.ca.ac.uk.ORCID http://orcid.org/0000-0003-0843-2468

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Implementing population-wide risk-stratified breast screening (RSBS) requires coordinated planning across diverse stakeholders and adaptation within complex healthcare systems. We convened a multi-stakeholder workshop with 34 policymakers, breast screening program leaders and healthcare professionals across Canada. Participants co-envisioned an RSBS program and focused on defining care pathways, the implementation roadmap, stakeholder engagement, and workforce training. A national, flexible RSBS strategy was proposed with multiple entry points and timings for risk assessment, interoperable information technology systems, phased roll-out, and an embedded learning healthcare system. The resulting actionable plans support RSBS implementation in Canada and offer transferable insights for planning RSBS in varied international settings.

Identifiers

PMID42014777
PMCPMC13109382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.